Main > ONCOLOGY (**) > GC/GEJ MET Adenocarcinoma> > USA. M. with High PD-L1 Expression

---

USA. M. with High PD-L1 Expression's subsections
(*) EU CE Mark Date: 2023. 12.18
>PD-1 Inhibitor+Fluoropyrimidine+Pt
Company
Patent>EU Patent Number
RTM
RTM Web-Site

USA. M. with High PD-L1 Expression's products
This section has no products